信義系擬捐出10萬個N95口罩及10萬盒快速檢測試劑
信義玻璃(00868.HK)、信義光能(00968.HK)、信義能源(03868.HK)及信義儲電(08328.HK)宣佈,爲支援香港新冠肺炎疫情防控工作,計劃捐助共10萬個N95口罩及10萬盒快速檢測試劑,物資將陸續抵港。
信義系首批援港抗疫物資已於2月14日由專車運抵香港,並全數捐贈新界社團聯會北區地區委員會,其中包括3,200盒快速試劑、5.04萬個N95口罩、2萬個醫用手套及3,200個隔離面罩,均爲疫情當下香港市民及防疫抗疫前線工作人員急需的物資。
信義玻璃及信義光能主席李賢義表示,疫情趨緊,集團始終關注香港疫情防控工作,將保障基層市民防疫物資供應穩定作爲主要着眼點,今年1月下旬信義系已捐贈6萬個防疫口罩,通過立法會議員派發給有需要的基層市民。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.